Literature DB >> 25783630

Extracellular Matrix Glycoprotein-Derived Synthetic Peptides Differentially Modulate Glioma and Sarcoma Cell Migration.

Nicole Brösicke1, Muhammad Sallouh, Lisa-Marie Prior, Albert Job, Ralf Weberskirch, Andreas Faissner.   

Abstract

Glycoproteins of the extracellular matrix (ECM) regulate proliferation, migration, and differentiation in numerous cell lineages. ECM functions are initiated by small peptide sequences embedded in large constituents that are recognized by specific cellular receptors. In this study, we have investigated the biological effects of peptides derived from collagen type IV and tenascin-C compared to the well-known RGD peptide originally discovered in fibronectin. The influence of glycoproteins and corresponding peptides on the migration of the glioma cell lines U-251-MG and U-373-MG and the sarcoma line S-117 was studied. When the cell lines were tested in a modified Boyden chamber assay on filters coated with the ECM glycoproteins, glioma cells showed a strong migration response on tenascin-C and the basal lamina constituent collagen IV, in contrast to S-117 cells. In order to identify relevant stimulatory motifs, peptides derived from fibronectin (6NHX-GRGDSF), tenascin-C (TN-C, VSWRAPTA), and collagen type IV (MNYYSNS) were compared, either applied in solution in combination with ECM glycoprotein substrates, in solution in the presence of untreated membranes, or coated on the filters of the Boyden chambers. Using this strategy, we could identify the novel tenascin-C-derived peptide motif VSWRAPTA as a migration stimulus for glioma cells. Furthermore, while kin peptides generally blocked the effects of the respective homologous ECM proteins, unexpected effects were observed in heterologous situations. There, in several cases, addition of soluble peptides strongly boosted the response to the coated ECM proteins. We propose that peptides may synergize or antagonize each other by stimulating different signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25783630     DOI: 10.1007/s10571-015-0170-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  62 in total

Review 1.  Fibronectins.

Authors:  R O Hynes
Journal:  Sci Am       Date:  1986-06       Impact factor: 2.142

2.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

3.  Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.

Authors:  S Chatterjee; A Matsumura; J Schradermeier; G Y Gillespie
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

4.  Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.

Authors:  Elena Victoria Rosca; Bachchu Lal; Jacob E Koskimaki; Aleksander S Popel; John Laterra
Journal:  Anticancer Drugs       Date:  2012-08       Impact factor: 2.248

Review 5.  Properties of human malignant glioma cells in vitro.

Authors:  J Pontén; B Westermark
Journal:  Med Biol       Date:  1978-08

6.  Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  Localization of a cryptic binding site for tenascin on fibronectin.

Authors:  Kenneth C Ingham; Shelesa A Brew; Harold P Erickson
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

8.  Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.

Authors:  I Nakamura; M F Pilkington; P T Lakkakorpi; L Lipfert; S M Sims; S J Dixon; G A Rodan; L T Duong
Journal:  J Cell Sci       Date:  1999-11       Impact factor: 5.285

9.  J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth.

Authors:  A Lochter; L Vaughan; A Kaplony; A Prochiantz; M Schachner; A Faissner
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

10.  Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors.

Authors:  C L Gladson; J N Wilcox; L Sanders; G Y Gillespie; D A Cheresh
Journal:  J Cell Sci       Date:  1995-03       Impact factor: 5.285

View more
  5 in total

1.  Knockdown of DIXDC1 Inhibits the Proliferation and Migration of Human Glioma Cells.

Authors:  Jianguo Chen; Chaoyan Shen; Jinlong Shi; Jianhong Shen; Wenjuan Chen; Jie Sun; Shaocheng Fan; Yuanqi Bei; Peng Xu; Hao Chang; Rui Jiang; Lu Hua; Bin Ji; Qingfeng Huang
Journal:  Cell Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.046

2.  NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression.

Authors:  Qizhi Qin; Mario Gomez-Salazar; Robert J Tower; Leslie Chang; Carol D Morris; Edward F McCarthy; Kang Ting; Xinli Zhang; Aaron W James
Journal:  Cancer Res       Date:  2022-08-03       Impact factor: 13.312

3.  The Tenascin-C-Derived Peptide VSWRAPTA Promotes Neuronal Branching Via Transcellular Activation of the Focal Adhesion Kinase (FAK) and the ERK1/2 Signaling Pathway In Vitro.

Authors:  Marvin Jarocki; Omar Sallouh; Ralf Weberskirch; Andreas Faissner
Journal:  Mol Neurobiol       Date:  2018-05-18       Impact factor: 5.590

4.  High expression of GALNT7 promotes invasion and proliferation of glioma cells.

Authors:  Shi Hua; Hongyan Li; Yuguang Liu; Jian Zhang; Yanhao Cheng; Chao Dai
Journal:  Oncol Lett       Date:  2018-09-25       Impact factor: 2.967

Review 5.  Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies.

Authors:  Andrew M K Law; Laura Rodriguez de la Fuente; Thomas J Grundy; Guocheng Fang; Fatima Valdes-Mora; David Gallego-Ortega
Journal:  Front Oncol       Date:  2021-11-30       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.